Cargando…
Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities
Off-label prescribing of medicines is prevalent worldwide because it gives freedom to physicians to apply new therapeutic options based on the latest evidence. Although physicians may lawfully prescribe approved drugs for any use consistent with available scientific data and proper medical practice,...
Autores principales: | Gupta, Sandeep Kumar, Nayak, Roopa Prasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008928/ https://www.ncbi.nlm.nih.gov/pubmed/24799811 http://dx.doi.org/10.4103/0976-500X.130046 |
Ejemplares similares
-
Non-inferiority clinical trials: Practical issues and current regulatory perspective
por: Gupta, Sandeep K.
Publicado: (2011) -
Pharmacovigilance Programme of India: Recent developments and future perspectives
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016) -
Use of Bayesian statistics in drug development: Advantages and challenges
por: Gupta, Sandeep K
Publicado: (2012) -
A study on the interactions of doctors with medical representatives of pharmaceutical companies in a Tertiary Care Teaching Hospital of South India
por: Gupta, Sandeep Kumar, et al.
Publicado: (2016) -
Learning How Drug Companies Promote Medicines in Nepal
por: Giri, Bishnu Rath, et al.
Publicado: (2005)